TickerFacts.

InfuSystem Holdings, Inc (INFU): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2018-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$63.14M
Year ended 2025-12-31
$60.98M
Trailing 12 months to 2026-06-30
+8.6%
3-year compound annual growth
$64.46M2009-12-31: $6.20M2010-12-31: $7.73M2011-12-31: $9.13M2012-12-31: $9.16M2013-12-31: $11.27M2014-12-31: $12.16M2015-12-31: $13.80M2016-12-31: $16.21M2017-12-31: $18.37M2018-12-31: $27.57M2019-12-31: $34.23M2020-12-31: $38.63M2021-12-31: $43.85M2022-12-31: $49.35M2023-12-31: $62.68M2024-12-31: $64.46M2025-12-31: $63.14M$63.14M
2009-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$63.14M-2.0%2026-02-27, From 2025-01-01
2024-12-31$64.46M+2.8%2026-02-27, From 2024-01-01
2023-12-31$62.68M+27.0%2025-03-11, From 2023-01-01
2022-12-31$49.35M+12.6%2024-04-10, From 2022-01-01
2021-12-31$43.85Mn/c2024-04-10, From 2021-01-01
2020-12-31$38.63M+12.8%2023-03-16, From 2020-01-01
2019-12-31$34.23M+24.2%2022-03-15, From 2019-01-01
2018-12-31$27.57Mn/c2020-03-30, From 2018-01-01
2017-12-31$18.37M+13.3%2019-03-22, From 2017-01-01
2016-12-31$16.21M+17.4%2018-03-19, From 2016-01-01
2015-12-31$13.80M+13.5%2017-03-22, From 2015-01-01
2014-12-31$12.16M+7.9%2016-12-12, From 2014-01-01
2013-12-31$11.27M+23.0%2015-03-09, From 2013-01-01
2012-12-31$9.16M+0.4%2014-03-11, From 2012-01-01
2011-12-31$9.13M+18.1%2013-03-28, From 2011-01-01
2010-12-31$7.73M+24.7%2012-03-16, From 2010-01-01
2009-12-31$6.20Mn/a2012-03-16, From 2009-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
InfuSystem Holdings, Inc (INFU)2025-12-31$63.14M-2.0%
Neuronetics, Inc. (STIM)2025-12-31$76.85M+270.7%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$49.65M+1.2%
Heartflow, Inc. (HTFL)2025-12-31$40.84M+30.2%
Orasure Technologies Inc (OSUR)2025-12-31$66.82M-37.2%
Anika Therapeutics, Inc. (ANIK)2025-12-31$49.01M+11.6%
SI-BONE, Inc. (SIBN)2025-12-31$41.05M+17.1%
Beta Bionics, Inc. (BBNX)2025-12-31$44.71M+52.9%
NeuroPace Inc (NPCE)2025-12-31$22.77M+9.3%

Compare INFU, STIM, XTNT, HTFL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗